2H-2-Ethyl Candesartan Cilexetil structure 
             | 
        Common Name | 2H-2-Ethyl Candesartan Cilexetil | ||
|---|---|---|---|---|
| CAS Number | 914613-36-8 | Molecular Weight | 638.71300 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 842.0±75.0 °C at 760 mmHg | |
| Molecular Formula | C35H38N6O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 463.1±37.1 °C | |
| Name | 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate | 
|---|---|
| Synonym | More Synonyms | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Boiling Point | 842.0±75.0 °C at 760 mmHg | 
| Molecular Formula | C35H38N6O6 | 
| Molecular Weight | 638.71300 | 
| Flash Point | 463.1±37.1 °C | 
| Exact Mass | 638.28500 | 
| PSA | 132.48000 | 
| LogP | 8.08 | 
| Vapour Pressure | 0.0±3.1 mmHg at 25°C | 
| Index of Refraction | 1.648 | 
| RIDADR | NONH for all modes of transport | 
|---|
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            2H-2-Ethyl Cand... CAS#:914613-36-8  | 
                                
| Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; | 
| 
                                        
                                        
                                        
                                        
                                         ~%  
                                            2H-2-Ethyl Cand... CAS#:914613-36-8  | 
                                
| Literature: Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            2H-2-Ethyl Cand... CAS#:914613-36-8  | 
                                
| Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; | 
| 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate | 
| 2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester | 
| UNII-ZRT0P1L622 | 
| 2-N-ethyl CNS | 
| 2H-2-Ethyl Candesartan Cilexetil | 
| Candesartan Cilexetil EP Impurity F | 
| ±1-(Cyclohexyloxycarbonyloxy)ethyl2-ethoxy-1-{[2’-(N-ethyl-tetrazol-5-yl) biphenyl-4-yl]methyl}benzimidazole-7-carboxylate | 
| Candesartan Cilexetil Impurity 6 |